UNITED STATES

OMB APPROVAL

 

SECURITIES AND EXCHANGE COMMISSION

OMB Number:
3235-0145

 

Washington, D.C. 20549

Expires:
December 31, 2005

 

 

Estimated average burden hours per response. . 11

 

SCHEDULE 13G

 

Under the Securities Exchange Act of 1934
(Amendment No.    )*

 

CYTOKINETICS INCORPORATED

(Name of Issuer)

 

Common Stock

(Title of Class of Securities)

 

23282W100

(CUSIP Number)

 

December 31, 2004

(Date of Event Which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

o

Rule 13d-1(b)

o

Rule 13d-1(c)

ý

Rule 13d-1(d)

 

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

 



 

CUSIP No.  24823Q107

 

 

1.

Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only)
Paul G. Allen

 

 

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

 

 

(a)

o

 

 

(b)

o

 

 

3.

SEC Use Only

 

 

4.

Citizenship or Place of Organization
United States of America

 

 

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

5.

Sole Voting Power
-0- shares

 

6.

Shared Voting Power 
2,314,700 shares (1)

 

7.

Sole Dispositive Power 
-0- shares

 

8.

Shared Dispositive Power
2,314,700 shares (1)

 

 

9.

Aggregate Amount Beneficially Owned by Each Reporting Person
2,314,700 shares(1)

 

 

10.

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  o

 

 

11.

Percent of Class Represented by Amount in Row (9)
8.1%(2)

 

 

12.

Type of Reporting Person (See Instructions)
IN

 


(1)          Directly owned by Vulcan Ventures Incorporated Paul G. Allen is the sole shareholder of Vulcan Ventures Incorporated and may be deemed to have shared voting and dispositive power with respect to these shares.

(2)          This percentage is based on 28,498,230 shares of common stock outstanding as of February 28, 2005 as reported on the Issuer’s Proxy Statement filed with the SEC on April 6, 2005.  Beneficial ownership is calculated in accordance with Rule 13d-3 promulgated under the Securities Exchange Act of 1934.

 

2



 

 

1.

Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only)
Vulcan Ventures Incorporated

 

 

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

 

 

(a)

o

 

 

(b)

o

 

 

3.

SEC Use Only

 

 

4.

Citizenship or Place of Organization
State of Washington

 

 

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

5.

Sole Voting Power
-0- shares

 

6.

Shared Voting Power 
2,314,700 shares (1)

 

7.

Sole Dispositive Power 
-0- shares

 

8.

Shared Dispositive Power
2,314,700 shares (1)

 

 

9.

Aggregate Amount Beneficially Owned by Each Reporting Person
2,314,700 shares (2)

 

 

10.

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  o

 

 

11.

Percent of Class Represented by Amount in Row (9)
8.1%(2)

 

 

12.

Type of Reporting Person (See Instructions)
CO

 


(1)          Directly owned by Vulcan Ventures Incorporated Paul G. Allen is the sole shareholder of Vulcan Ventures Incorporated and may be deemed to have shared voting and dispositive power with respect to these shares.

(2)          This percentage is based on 28,498,230 shares of common stock outstanding as of February 28, 2005 as reported on the Issuer’s Proxy Statement filed with the SEC on April 6, 2005.  Beneficial ownership is calculated in accordance with Rule 13d 3 promulgated under the Securities Exchange Act of 1934.

 

3



 

Item 1.

 

(a)

Name of Issuer
Cytokinetics, Inc.

 

(b)

Address of Issuer’s Principal Executive Offices
280 East Grand Ave.
South San Francisco, CA  94080

 

Item 2.

 

(a)

Name of Person Filing
Paul G. Allen and Vulcan Ventures Incorporated

 

(b)

Address of Principal Business Office or, if none, Residence
The address for both filing persons is as follows:

505 Union Station, Suite 900
Seattle, Washington  98104

 

(c)

Citizenship
Paul G. Allen is a citizen of the United States of America. 
Vulcan Ventures Incorporated is a corporation organized under the laws of the State of Washington.

 

(d)

Title of Class of Securities
Common Stock

 

(e)

CUSIP Number
23282W100

 

Item 3.

If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

 

(a)

o

Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

 

(b)

o

Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

 

(c)

o

Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

 

(d)

o

Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8).

 

(e)

o

An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);

 

(f)

o

An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);

 

(g)

o

A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

 

(h)

o

A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

 

(i)

o

A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

 

(j)

o

Group, in accordance with §240.13d-1(b)(1)(ii)(J).

 

Not applicable.

 

 

Item 4.

Ownership

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

 

(a)

Amount beneficially owned:   
2,314,700 shares (1)

 

(b)

Percent of class:   
8.1% (2)

 

(c)

Number of shares as to which the person has:

 

 

(i)

Sole power to vote or to direct the vote   
-0- shares

 

 

(ii)

Shared power to vote or to direct the vote    
2,314,700 shares (1)

 

 

(iii)

Sole power to dispose or to direct the disposition of   
-0- shares

 

 

(iv)

Shared power to dispose or to direct the disposition of   
2,314,700 shares (1)

 


(1)          The shares are owned directly by Vulcan Ventures Incorporated and beneficially by Paul G. Allen, the sole shareholder of Vulcan Ventures Incorporated Vulcan Ventures Incorporated and Mr. Allen may be deemed to have shared voting and dispositive power with respect to these shares.

(2)          This percentage is based on 28,498,230 shares of common stock outstanding as of February 28, 2005 as reported on the Issuer’s Proxy Statement filed with the SEC on April 6, 2005.  Beneficial ownership is calculated in accordance with Rule 13d-3 promulgated under the Securities Exchange Act of 1934.

 

4



 

Item 5.

Ownership of Five Percent or Less of a Class

 

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following   o.

 

Item 6.

Ownership of More than Five Percent on Behalf of Another Person

 

Not applicable.

 

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person

 

Not applicable.

 

Item 8.

Identification and Classification of Members of the Group

 

Not applicable.

 

Item 9.

Notice of Dissolution of Group

 

Not applicable.

 

Item 10.

Certification

 

Not applicable.

 

5



 

SIGNATURES

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

 

VULCAN VENTURES INCORPORATED

May     , 2005

 

 

 

 

 

 

By:

/s/ W. Lance Conn 

 

 

Name and Title:

W. Lance Conn, Executive Vice President

 

 

 

 

 

 

 

May     , 2005

/s/ W. Lance Conn

 

 

Paul G. Allen

 

 

 

 

 

*By:

/s/ W. Lance Conn

 

 

Name:

/s/ W. Lance Conn 

 

 

 

Attorney-in Fact for Paul G. Allen

 

 



 

EXHIBIT INDEX

 

Exhibit

 

Description

 

 

 

99.1

 

Joint Filing Agreement

 


EXHIBIT 99.1

 

Joint Filing Agreement

 

We, the signatories of the statement to which this Joint Filing Agreement is attached, hereby agree that such statement is filed, and any amendments thereto by either or both of us will be filed, on behalf of each of us.

 

 

Dated: May     , 2005

VULCAN VENTURES INCORPORATED

 

 

 

 

 

 

 

 

By:

/s/ W. Lance Conn

 

 

Name and Title:

/s/ W. Lance Conn, Executive Vice President

 

 

 

 

 

 

 

Dated: May     , 2005

/s/ W. Lance Conn

 

 

 Paul G. Allen

 

 

 

 

 

 

 

 

*By:

/s/ W. Lance Conn

 

 

Name:

/s/ W. Lance Conn

 

 

 

Attorney-in Fact for Paul G. Allen